PTC Therapeutics chairman sells 2,500 shares
PTC Therapeutics Chairman Michael Schmertzler sold 2,500 shares at $63.39, worth $158,480, according to a Form 4 filing. The filing said the sale was made under a 10b5-1 plan.
PTC Therapeutics Chairman Michael Schmertzler sold 2,500 shares at $63.39, worth $158,480, according to a Form 4 filing. The filing said the sale was made under a 10b5-1 plan.